Observational Study to Evaluate the Safety of Levemir® in Diabetes

• Status: Completed
• Trial end date: 2008-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This observational study is conducted in North America. The aim of this observational study is to evaluate the incidence of adverse events while using Levemir® under normal clinical practice conditions.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Insulin; Insulin Detemir

Criteria

Inclusion Criteria:

• Type 1 or 2 diabetes

• Including newly diagnosed not on insulin or insulin analogue treatment

• Selection at the discretion of the physician

• Adult patients with type 1 and 2 diabetes mellitus, and type 1 patients 6 years and older

Exclusion Criteria:

• Current treatment with Levemir®

• Previously enrolled in the study

• Hypersensitivity to Levemir®